Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program
This study has been completed.
Sponsor:
Ringkobing Love Apotek
Collaborator:
Ministry of Health and Prevention
Information provided by:
Ringkobing Love Apotek
ClinicalTrials.gov Identifier:
NCT00916214
First received: June 1, 2009
Last updated: June 13, 2011
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. The specific objective of the project is to determine effects of pharmaceutical care program on medication adherence and persistence among elderly polypharmacy users.
| Condition | Intervention | Phase |
|---|---|---|
|
Polypharmacy |
Other: Pharmaceutical care program |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program |
Further study details as provided by Ringkobing Love Apotek:
Primary Outcome Measures:
- change in medication adherence from run-in to the end of phase 1 [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- persistence of mean medication adherence [ Time Frame: 12 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | June 2009 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Intervention |
Other: Pharmaceutical care program
The pharmaceutical care program consists of 2 elements, that includes individualized medication education and regular follow up
|
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Both men and woman aged more than 65 years and taking more than 2 drugs
Exclusion Criteria:
- Inhabitants of nursing homes
- People receiving unit dose dispensing of medicine
Contacts and Locations More Information
No publications provided
| Responsible Party: | Muhammad Saeed, Ringkøbing Løve Apotek |
| ClinicalTrials.gov Identifier: | NCT00916214 History of Changes |
| Other Study ID Numbers: | RLA Trial |
| Study First Received: | June 1, 2009 |
| Last Updated: | June 13, 2011 |
| Health Authority: | Denmark: The Regional Committee on Biomedical Research Ethics Denmark: The Ministry of Health & Prevention Denmark: Datatilsynet |
ClinicalTrials.gov processed this record on June 18, 2013